Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for heparin-induced thrombocytopenia

2 trials tracked for heparin-induced thrombocytopenia.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 1 1 Other / NA 1
  1. Phase 1 Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis Completed
  2. N/A Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Argatroban switch stabilized clinical status in a patient with mechanical aortic valve and LVAD after HIT
Cardiology Sys. Review
Argatroban switch stabilized clinical status in a patient with mechanical aortic valve and LVAD after HIT Blood thinner switch stabilizes LVAD patient with rare clotting disorder
This case report describes the management of heparin-induced thrombocytopenia (HIT) in a patient with a mechanical aortic valve and left ven…
A patient with a mechanical heart valve and LVAD developed dangerous clots after heparin. Switching to argatroban stabilized their condition…
Frontiers Jun 11, 2026
This narrative review examines immune-mediated thrombocytopenia and thrombotic thrombocytopenic purpura conditions without specific intervention data or reported outcomes
Neurology Sys. Review
This narrative review examines immune-mediated thrombocytopenia and thrombotic thrombocytopenic purpura conditions without specific intervention data or reported outcomes Review of rare blood disorders offers general overview of treatment options
This narrative review explores immune-mediated thrombocytopenia and thrombotic thrombocytopenic purpura. No specific interventions, outcomes…
This narrative review discusses immune thrombocytopenia and related conditions without reporting new findings or specific patient outcomes.
Frontiers May 26, 2026
Observational study identifies PF4-dependent antibodies in ELISA-negative HIT patients via functional testing
Hematology
Observational study identifies PF4-dependent antibodies in ELISA-negative HIT patients via functional testing Could stopping blood thinners because of a false negative test actually harm you?
This observational research article with an animal component evaluates PF4-dependent platelet-activating antibodies in ELISA-negative patien…
Standard blood tests for a dangerous clotting disorder missed six patients, leading doctors to stop life-saving medicine and causing new clo…
medRxiv Apr 18, 2026